Literature DB >> 27662555

Buy one, get one free? Benefits of certain antiretrovirals against malaria.

Charlotte V Hobbs1, Sunil Parikh.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 27662555      PMCID: PMC5718339          DOI: 10.1097/QAD.0000000000001266

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  18 in total

1.  HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study.

Authors:  Kimberly A Porter; Stephen R Cole; Joseph J Eron; Yu Zheng; Michael D Hughes; Shahin Lockman; Charles Poole; Tina S Skinner-Adams; Mina Hosseinipour; Doug Shaffer; Ronald D'Amico; Frederick K Sawe; Abraham Siika; Elizabeth Stringer; Judith S Currier; Tsungai Chipato; Robert Salata; James S McCarthy; Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

2.  The effect of antiretrovirals on Plasmodium falciparum liver stages.

Authors:  Charlotte V Hobbs; Patricia De La Vega; Scott R Penzak; Jillian Van Vliet; Urszula Krzych; Photini Sinnis; William Borkowsky; Patrick E Duffy
Journal:  AIDS       Date:  2013-06-19       Impact factor: 4.177

3.  Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors.

Authors:  Sunil Parikh; Jiri Gut; Eva Istvan; Daniel E Goldberg; Diane V Havlir; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  The epidemiological impact of HIV antiretroviral therapy on malaria in children.

Authors:  Scott Greenhalgh; Martial Ndeffo; Alison P Galvani; Sunil Parikh
Journal:  AIDS       Date:  2015-02-20       Impact factor: 4.177

5.  HIV treatments have malaria gametocyte killing and transmission blocking activity.

Authors:  Charlotte V Hobbs; Takeshi Q Tanaka; Olga Muratova; Jillian Van Vliet; William Borkowsky; Kim C Williamson; Patrick E Duffy
Journal:  J Infect Dis       Date:  2013-03-28       Impact factor: 5.226

6.  Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.

Authors:  U Lek-Uthai; R Suwanarusk; R Ruengweerayut; T S Skinner-Adams; F Nosten; D L Gardiner; P Boonma; K A Piera; K T Andrews; B Machunter; J S McCarthy; N M Anstey; R N Price; B Russell
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

7.  The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir.

Authors:  Thomas E Kraft; Christopher Armstrong; Monique R Heitmeier; Audrey R Odom; Paul W Hruz
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

8.  The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment.

Authors:  Tina S Skinner-Adams; Alice S Butterworth; Kimberly A Porter; Ronald D'Amico; Fred Sawe; Doug Shaffer; Abraham Siika; Mina C Hosseinipour; Elizabeth Stringer; Judith S Currier; Tsungai Chipato; Robert Salata; Shahin Lockman; Joseph J Eron; Steven R Meshnick; James S McCarthy
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

9.  Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults.

Authors:  Ronnie P Kasirye; Heiner Grosskurth; Paula Munderi; Jonathan Levin; Zacchaeus Anywaine; Andrew Nunn; Anatoli Kamali; Kathy Baisley
Journal:  AIDS       Date:  2017-02-20       Impact factor: 4.177

10.  Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.

Authors:  Sunil Parikh; Richard Kajubi; Liusheng Huang; Joshua Ssebuliba; Sylvia Kiconco; Qin Gao; Fangyong Li; Moses Were; Abel Kakuru; Jane Achan; Norah Mwebaza; Francesca T Aweeka
Journal:  Clin Infect Dis       Date:  2016-05-03       Impact factor: 9.079

View more
  4 in total

1.  Brief Report: Antimalarial Benefit of HIV Antiretroviral Therapy in Areas of Low to Moderate Malaria Transmission Intensity.

Authors:  Scott Greenhalgh; Charlotte V Hobbs; Sunil Parikh
Journal:  J Acquir Immune Defic Syndr       Date:  2018-10-01       Impact factor: 3.731

2.  Inhibition of Plasmodium Hepatic Infection by Antiretroviral Compounds.

Authors:  Marta Machado; Margarida Sanches-Vaz; João P Cruz; António M Mendes; Miguel Prudêncio
Journal:  Front Cell Infect Microbiol       Date:  2017-07-19       Impact factor: 5.293

3.  Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy.

Authors:  Charlotte V Hobbs; Erin E Gabriel; Portia Kamthunzi; Gerald Tegha; Jean Tauzie; Yonghua Li; Tiina Ilmet; Elena Artimovich; Jillian Neal; Ted Hall; Sunil Parikh; Brian Kirmse; Patrick Jean-Philippe; Jingyang Chen; William R Prescott; Paul Palumbo; Patrick E Duffy; William Borkowsky
Journal:  Am J Trop Med Hyg       Date:  2018-01       Impact factor: 2.345

Review 4.  Repurposing Drugs to Fight Hepatic Malaria Parasites.

Authors:  Diana Fontinha; Isabel Moules; Miguel Prudêncio
Journal:  Molecules       Date:  2020-07-28       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.